Dialysis At Yours, Life Fulfilled (DAYLife): Improving the quality and uptake of dialysis at home in the UK
Review of home therapies provision in the context of COVID-19
Please respond for both home modalities – home haemodialysis (HHD) and peritoneal dialysis (PD)
OK
1.
Please state the renal hospital you work at:
2.
What is your current role?
Doctor
Nurse
Allied Health Professional
Manager
Other (please specify)
3.
Home Therapies Workforce:
Did your work-force change or be redeployed as a result of COVID-19 and what was the impact of this on home therapy care provision?
4.
Patient Training for Home Therapies (HHD and PD):
Did you change or stop training patients to go home during COVID-19?
(What did you have to change about your training programmes and its delivery, what was the impact? What would have made a difference in terms of supporting patient training and getting patients safely home? How could they have been supported?)
5.
Industry providers of Home Therapies (HHD and PD):
Did industry partners support and communicate with you during COVID-19?
(Was there anything industry could have done better, more of, less of?)
6.
Transplantation:
Were those on a home therapy de-activated from the transplant list during the COVID-19 pandemic, or were all transplants stopped? How did this impact your home therapies programme?
7.
Access:
Was provision of access surgery limited due to COVID-19 and how did this impact on your home therapies programme? (please return on both PD and HD access)
8.
Access:
How have medical insertions made a difference to home therapy service delivery?
9.
Access:
Are there plans for restoration of services?
10.
Decision Making:
Have the risks of acquiring COVID-19 whilst dialysing in-centre changed your renal centre’s service planning with regards to provision of home dialysis
(HHD and PD)?
11.
Decision Making:
Have the risks of acquiring COVID-19 whilst dialysing in-centre changed the way decisions regarding treatment choice are reached / conversations are had between HCP and patients?
12.
Support:
How has the information, follow-up and support provided by your renal team to people dialysing at home changed during COVID-19?
(e.g. Use of technology to support home patients and the impact of use of Remote Patient Management)
13.
Beneficial changes:
Are there any changes that have occurred that you would like to keep?
14.
Beneficial changes:
Are there any changes you have not implemented but that you would like to make to ensure a safe and sustainable home therapies programme?
(What could have been done if anything to support units to maintain home programmes?)
15.
What would you like to stop/get rid of?
16.
Patient Feedback during COVID:
Any patient feedback regarding Home Therapies
(HHD and PD)
captured during COVID both at the low clearance stage and also from those already on a home therapy?
Current Progress,
0 of 16 answered
